Gardner DM - Search Results

1

Gardner DM, Kutcher S. Gardner DM, et al. Can J Psychiatry. 1993 Mar;38(2):113-6. doi: 10.1177/070674379303800208. Can J Psychiatry. 1993. PMID: 8467436

2

Anxiety disorders in children and adolescents: clinical and related issues in pharmacological treatment.

Reiter S, Kutcher S, Gardner D. Reiter S, et al. Can J Psychiatry. 1992 Aug;37(6):432-8. doi: 10.1177/070674379203700615. Can J Psychiatry. 1992. PMID: 1394022 Review.

3

The pharmacotherapy of anxiety disorders in children and adolescents.

Kutcher SP, Reiter S, Gardner DM, Klein RG. Kutcher SP, et al. Among authors: gardner dm. Psychiatr Clin North Am. 1992 Mar;15(1):41-67. Psychiatr Clin North Am. 1992. PMID: 1549548 Review.

4

The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.

Kutcher S, Papatheodorou G, Reiter S, Gardner D. Kutcher S, et al. J Psychiatry Neurosci. 1995 Mar;20(2):113-8. J Psychiatry Neurosci. 1995. PMID: 7703220 Free PMC article.

5

Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions.

Shulman KI, Tailor SA, Walker SE, Gardner DM. Shulman KI, et al. Among authors: gardner dm. Can J Psychiatry. 1997 Apr;42(3):310-2. doi: 10.1177/070674379704200311. Can J Psychiatry. 1997. PMID: 9114949

6

Serotonin syndrome with prolonged dysphagia.

Passmore MJ, Devarajan S, Ghatavi K, Gardner DM, Kutcher SP. Passmore MJ, et al. Among authors: gardner dm. Can J Psychiatry. 2004 Jan;49(1):79-80. doi: 10.1177/070674370404900127. Can J Psychiatry. 2004. PMID: 14763689 No abstract available.

7

Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths.

Carandang C, Santor D, Gardner DM, Carrey N, Kutcher S. Carandang C, et al. Among authors: gardner dm. J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):489-492. doi: 10.1097/chi.0b013e31802f5f54. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17420683 No abstract available.

8

Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story.

Kutcher S, Gardner DM. Kutcher S, et al. Among authors: gardner dm. Curr Opin Psychiatry. 2008 Jan;21(1):65-9. doi: 10.1097/YCO.0b013e3282f29853. Curr Opin Psychiatry. 2008. PMID: 18281842 Review.

9

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders.

Kutcher S, Brooks SJ, Gardner DM, Honer B, Kopala L, Labelle A, Lalonde P, Malla A, Milliken H, Soni J, Williams R. Kutcher S, et al. Among authors: gardner dm. Neuropsychiatr Dis Treat. 2005 Jun;1(2):89-108. doi: 10.2147/nedt.1.2.89.61042. Neuropsychiatr Dis Treat. 2005. PMID: 18568067 Free PMC article.

10

An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression.

Boulos C, Kutcher S, Gardner D, Young E. Boulos C, et al. J Child Adolesc Psychopharmacol. 1992 Summer;2(2):103-11. doi: 10.1089/cap.1992.2.103. J Child Adolesc Psychopharmacol. 1992. PMID: 19630647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters